Norharmane

Overview

Norharmane (Norharman), a β-carboline alkaloid, is a potent and reversible monoamine oxidase inhibitor, with IC 50 values of 6.5 and 4.7 μM for MAO-A and MAO-B , respectively. Norharmane causes antidepressant responses. Norharmane is also a prospective anti-cancer photosensitizer . Norharmane alters polar auxin transport (PAT) by inhibiting PIN2, PIN3 and PIN7 transport proteins, thus causing a significant inhibitory effect on the growth of Arabidopsis thaliana seedlings.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-W008566
• CAS No.: 244-63-3
• Molecular Formula: C11H8N2
• Molecular Weight: 168.20
• Purity: 99.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1.1 mg/mL (6.54 mM); Clear solution
• Availability: In-stock

Source

Original product source